Legal Representation
Attorney
Muzamil Huq
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 28, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 28, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 14, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 13, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 6, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 6, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 29, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 27, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 27, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 19, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 19, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 19, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 27, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 2, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 2, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 12, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 30, 2023 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 23, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 7, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 7, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 7, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 6, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Feb 28, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Feb 10, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 10, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 10, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 10, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 10, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 2, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 2, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Aug 4, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 4, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Aug 4, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 4, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 3, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 3, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 4, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 4, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 4, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 3, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 23, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and diagnostic preparations for the treatment of ophthalmic conditions; drug delivery systems comprised of topically-applied liquids, ointments, creams, and gels for the delivery of ophthalmic pharmaceuticals and preparations
Class 010
Medical devices for treatment of ophthalmic conditions; drug delivery systems comprised of devices for the delivery of ophthalmic pharmaceuticals and preparations via injection and implants, sold without medication
Classification
International Classes
005
010